Arkolith/Insider Trading/ACAD/Form 4

Kihara James

PRINCIPAL ACCOUNTING OFFICERACADIA PHARMACEUTICALS INC (ACAD) · full profile →Form 4 · filed Mar 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$42K
Net Open-Market Flow
-$42K
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 26, 2026Sell(S)12$21.73$26127K
Mar 26, 2026Sell(S)1K$21.65$24K27K
Mar 25, 2026Sell(S)833$21.47$18K26K
Mar 25, 2026Option exercise(M)2K——28K
Mar 24, 2026Option exercise(M)2K——27K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 25, 2026Option exercise(M)2K—$04K
Mar 24, 2026Option exercise(M)2K—$05K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001816160-26-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML